Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation
- PMID: 11196106
- DOI: 10.1023/a:1026708618507
Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation
Abstract
We characterized the effect of orthotopic liver transplantation on the catabolism of branched-chain L-amino acids in a female patient with classical form of maple syrup urine disease. Transplantation was performed at the age of 7.4 years due to a terminal liver failure triggered by a hepatitis A infection. Since then, the patient is on an unrestricted diet and plasma concentrations of branched-chain L-amino and 2-oxo acids are stable, yet at moderately increased levels (2- to 3-fold of control). L-Alloisoleucine concentrations, however, remained remarkably elevated (> 5-fold of control). In vivo catabolism was investigated by measuring the metabolic L-alloisoleucine clearance and whole-body leucine oxidation in the postabsorptive state. In an oral loading test with 580 micromol alloisoleucine per kg body wt, the L-alloisoleucine elimination rate constant (0.067 h(-1)) was in the normal range (0.069+/-0.012 h(-1), n = 4). In an oral L-[1-13C]leucine load (38 micromol/kg body wt), 19.5% of the tracer dose applied was recovered in exhaled 13CO2 versus 18.9+/-3.6% in healthy subjects (n = 10). Thus, the patient exhibited obviously normal whole-body catabolic rates although branched-chain L-amino acid oxidation was confined to the liver transplant. Most likely, the enhanced substrate supply from extrahepatic sources led to an elevation of the plasma concentrations and thus induced a compensatory enhancement of the metabolic flux through the branched-chain 2-oxo acid dehydrogenase complex in the intact liver tissue.
Similar articles
-
Domino liver transplantation in maple syrup urine disease.Liver Transpl. 2006 May;12(5):876-82. doi: 10.1002/lt.20744. Liver Transpl. 2006. PMID: 16628687
-
Diagnosis and treatment of maple syrup disease: a study of 36 patients.Pediatrics. 2002 Jun;109(6):999-1008. doi: 10.1542/peds.109.6.999. Pediatrics. 2002. PMID: 12042535
-
Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.Clin Chem. 1999 Oct;45(10):1734-40. Clin Chem. 1999. PMID: 10508118
-
Metabolism of branched-chain amino acids in maple syrup urine disease.Eur J Pediatr. 1997 Aug;156 Suppl 1:S62-6. doi: 10.1007/pl00014274. Eur J Pediatr. 1997. PMID: 9266218 Review.
-
Successful pregnancy in maple syrup urine disease: a case report and review of the literature.Nutr J. 2018 May 12;17(1):51. doi: 10.1186/s12937-018-0357-7. Nutr J. 2018. PMID: 29753318 Free PMC article. Review.
Cited by
-
Production and characterization of murine models of classic and intermediate maple syrup urine disease.BMC Med Genet. 2006 Mar 31;7:33. doi: 10.1186/1471-2350-7-33. BMC Med Genet. 2006. PMID: 16579849 Free PMC article.
-
Animal models of maple syrup urine disease.J Inherit Metab Dis. 2009 Apr;32(2):229-46. doi: 10.1007/s10545-009-1086-z. Epub 2009 Mar 9. J Inherit Metab Dis. 2009. PMID: 19263237 Review.
-
Acute Metabolic Crises in Maple Syrup Urine Disease After Liver Transplantation from a Related Heterozygous Living Donor.JIMD Rep. 2016;30:59-62. doi: 10.1007/8904_2016_532. Epub 2016 Apr 28. JIMD Rep. 2016. PMID: 27117295 Free PMC article.
-
Ataxia in children: early recognition and clinical evaluation.Ital J Pediatr. 2017 Jan 13;43(1):6. doi: 10.1186/s13052-016-0325-9. Ital J Pediatr. 2017. PMID: 28257643 Free PMC article. Review.
-
Drosophila miR-277 controls branched-chain amino acid catabolism and affects lifespan.RNA Biol. 2013 Jun;10(6):1042-56. doi: 10.4161/rna.24810. Epub 2013 Apr 30. RNA Biol. 2013. PMID: 23669073 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical